The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Association between competing interests and authors' conclusions: epidemiological study of randomised clinical trials published in the BMJ
Open accessAbstract
Objective : To assess the association between competing interests and authors' conclusions in randomised clinical trials. Design : Epidemiological study of randomised clinical trials published in the BMJ from January 1997 to June 2001. Financial competing interests were defined as funding by for profit organisations and other competing interests as personal, academic, or political. Studies : 159 trials from 12 medical specialties. Main outcome measures : Authors' conclusions defined as interpretation of extent to which overall results favoured experimental intervention. Conclusions appraised on 6 point scale; higher scores favour experimental intervention. Results : Authors' conclusions were significantly more positive towards the experimental intervention in trials funded by for profit organisations alone compared with trials without competing interests (mean difference 0.48 (SE 0.13), P=0.014), trials funded by both for profit and non-profit organisations (0.30 (SE 0.10), P=0.003), and trials with other competing interests (0.45 (SE 0.13), P=0.006). Other competing interests and funding from both for profit and non-profit organisations were not significantly associated with authors' conclusions. The association between financial competing interests and authors' conclusions was not explained by methodological quality, statistical power, type of experimental intervention (pharmacological or non-pharmacological), type of control intervention (for example, placebo or active drug), or medical specialty. Conclusions : Authors' conclusions in randomised clinical trials significantly favoured experimental interventions if financial competing interests were declared. Other competing interests were not significantly associated with authors' conclusions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Schulz (1995) · doi:10.1001/jama.1995.03520290060030 · Cited by 5,634
Moher, D., Schulz, K. F., & Altman, D. G. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04337-3 · Cited by 5,373
Moher, D., Pham, B., Jones, A., Cook, D. J., Jadad, A. R., Moher, M., Tugwell, P., & Klassen, T. P. (1998) · The Lancet · doi:10.1016/s0140-6736(98)01085-x · Cited by 3,560
Improving the Quality of Reporting of Randomized Controlled Trials: The CONSORT Statement
Begg, C. (1996) · JAMA · doi:10.1001/jama.1996.03540080059030 · Cited by 3,127
Publication bias in clinical research
Easterbrook, P. J., Gopalan, R., Berlin, J. A., & Matthews, D. R. (1991) · The Lancet · doi:10.1016/0140-6736(91)90201-y · Cited by 3,109
Moher, D., Schulz, K. F., & Altman, D. G. (2001) · BMC Medical Research Methodology · doi:10.1186/1471-2288-1-2 · Cited by 2,755
Kjaergard, L. L., Villumsen, J., & Gluud, C. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-11-200112040-00010 · Cited by 2,283
Self-citationThe uncertainty principle and industry-sponsored research
Djulbegovic, B., Lacevic, M., Cantor, A., Fields, K. K., Bennett, C. L., Adams, J. R., Kuderer, N. M., & Lyman, G. H. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02605-2 · Cited by 482
Sponsorship, Authorship, and Accountability
Davidoff, F. (2001) · JAMA · doi:10.1001/jama.286.10.1232 · Cited by 202
Beyond conflict of interestA common problemBuilding a convincing caseWhat should the BMJ be doing?
Smith, R. W. (1998) · BMJ · doi:10.1136/bmj.317.7154.291 · Cited by 145
Statistics Notes: Comparing several groups using analysis of variance
Altman, D. G., & Bland, M. (1996) · BMJ · doi:10.1136/bmj.312.7044.1472 · Cited by 86
Edwards, R., & Bhopal, R. (1999) · PubMed · doi:10.25405/ncl.34642230 · Cited by 64
Sponsorship, Authorship, and Accountability
Davidoff, F., DeAngelis, C. D., Drazen, J. M., Hoey, J., Højgaard, L., Horton, R., Kotzin, S., Nylenna, M., Overbeke, A. J. P. M., Sox, H. C., et al. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-6-200109180-00016 · Cited by 58
Are randomised controlled trials in the BMJ different?
Egger, M., Bartlett, C., & Jüni, P. (2001) · BMJ · doi:10.1136/bmj.323.7323.1253a · Cited by 55
Dieppe, P. A., Chard, J., Tallon, D., & Egger, M. (1999) · The Lancet · doi:10.1016/s0140-6736(05)75755-x · Cited by 32
Duchenne muscular dystrophy: relevant paper was not included
Smith, R. A., & Phillips, R. S. (2001) · BMJ · doi:10.1136/bmj.323.7323.1253 · Cited by 13
Research works printed but not linked: 1
- Wahlbeck, 1999, Beyond conflict of interest. Sponsored drug trials show more favourable outcomes., BMJ, 318, 465
Cited by
Moher, D., Hopewell, S., Schulz, K. F., Montori, V., Gotzsche, P. C., Devereaux, P. J., Elbourne, D., Egger, M., & Altman, D. G. (2010) · BMJ · doi:10.1136/bmj.c869 · Cited by 8,883
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
Chan, A.-W., Tetzlaff, J. M., Gotzsche, P. C., Altman, D. G., Mann, H., Berlin, J. A., Dickersin, K., Hrobjartsson, A., Schulz, K. F., Parulekar, W. R., et al. (2013) · BMJ · doi:10.1136/bmj.e7586 · Cited by 6,251
Moher, D., Hopewell, S., Schulz, K. F., Montori, V., Gøtzsche, P. C., Devereaux, P. J., Elbourne, D., Egger, M., & Altman, D. G. (2012) · International Journal of Surgery · doi:10.1016/j.ijsu.2011.10.001 · Cited by 2,345
Moher, D., Hopewell, S., Schulz, K. F., Montori, V., Gøtzsche, P. C., Devereaux, P. J., Elbourne, D., Egger, M., & Altman, D. G. (2010) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.03.004 · Cited by 1,858
Scope and Impact of Financial Conflicts of Interest in Biomedical Research: A Systematic Review
Bekelman, J. E., Li, Y., & Gross, C. P. (2003) · JAMA · doi:10.1001/jama.289.4.454 · Cited by 1,816
“An analysis of 159 RCTs also reported that trials funded by for-profit organizations were more likely to use an inactive control.(48) In the analysis of NSAID RCTs, the dose of the industry-associated drug was higher than that of the comparison drug in 27 trials (48%), although the dosing was comparable in 23 trials (…”
Metadata
- Authors
- Kjaergard, L., & Als-Nielsen, B.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2002-08-03
- Volume
- 325
- Issue
- 7358
- Pages
- 249
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2056651344
- Cited by
- 433
- References
- 16
- FWCI
- 17.12
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.bmj.com/company/legal-information/terms-conditions/legal-information/tdm-licencepolicy (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.